B cell non-hodgkin lymphoma – pipeline
Upcoming SlideShare
Loading in...5

Like this? Share it with your network


B cell non-hodgkin lymphoma – pipeline

Uploaded on

Aarkstore Enterprise-B cell non-hodgkin lymphoma – pipeline

Aarkstore Enterprise-B cell non-hodgkin lymphoma – pipeline

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On Slideshare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, GlobalMarkets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012,provides an overview of the indication’s therapeutic pipeline. This report providesinformation on the therapeutic development for B-Cell Non-Hodgkin Lymphoma,complete with latest updates, and special features on late-stage and discontinuedprojects. It also reviews key players involved in the therapeutic development for B-Cell Non-Hodgkin Lymphoma. B-Cell Non-Hodgkin Lymphoma - Pipeline Review,Half Year is built using data and information sourced from Global Markets Direct’sproprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for B-Cell Non-Hodgkin Lymphoma.- A review of the B-Cell Non-Hodgkin Lymphoma products under development by
  • 2. companies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for B-Cell Non-Hodgkin Lymphoma.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.Table of contents:List of Tables 6List of Figures 7Introduction 8Global Markets Direct Report Coverage 8B-Cell Non-Hodgkin Lymphoma Overview 9Therapeutics Development 10An Overview of Pipeline Products for B-Cell Non-Hodgkin Lymphoma 10B-Cell Non-Hodgkin Lymphoma Therapeutics under Development by Companies 12B-Cell Non-Hodgkin Lymphoma Therapeutics under Investigation byUniversities/Institutes 15Late Stage Products 18Comparative Analysis 18Mid Clinical Stage Products 19Comparative Analysis 19Early Clinical Stage Products 20Comparative Analysis 20Discovery and Pre-Clinical Stage Products 21Comparative Analysis 21B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Development byCompanies 22B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Investigation byUniversities/Institutes 24
  • 3. Companies Involved in B-Cell Non-Hodgkin Lymphoma Therapeutics Development28Bristol-Myers Squibb Company 28Johnson & Johnson 29Kyowa Hakko Kirin Co., Ltd. 30Sanofi-Aventis 31Genentech, Inc. 32MedImmune LLC 33Gilead Sciences, Inc. 34List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1 Liver Cancer – Pipeline Review, H2 2012 Non-Small Cell Lung Cancer – Pipeline Review, H2 2012 Asthma – Pipeline Review, H2 2012 Multiple Sclerosis – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012
  • 4. Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com